TY - JOUR
T1 - Identification of the gene responsible for gelatinous drop-like corneal dystrophy
AU - Tsujikawa, Motokazu
AU - Kurahashi, Hiroki
AU - Tanaka, Toshihiro
AU - Nishida, Kohji
AU - Shimomura, Yoshikazu
AU - Tano, Yasuo
AU - Nakamura, Yusuke
N1 - Funding Information:
This work was supported by a Research on Human Genome and Gene Therapy grant from Ministry of Health and Welfare of Japan.
Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1999/4
Y1 - 1999/4
N2 - Gelatinous drop-like corneal dystrophy (GDLD; OMIM 204870) is an autosomal recessive disorder characterized by severe corneal amyloidosis leading to blindness, with an incidence of 1 in 300,000 in Japan. Our previous genetic linkage study localized the gene responsible to a 2.6-cM internal on chromosome 1p (ref. 6). Clinical manifestations, which appear in the first decade of life, include blurred vision, photophobia and foreign- body sensation. By the third decade, raised, yellowish-grey, gelatinous masses severely impair visual acuity, and lamellar keratoplasty is required for most patients. Here we report DNA sequencing, cDNA cloning and mutational analyses of four deleterious mutations (Q118X, 632delA, Q207X and S170X) in M1S1 (formerly TROP2 and GA733-1), encoding a gastrointestinal tumour- associated antigen. The Q118X mutation was the most common alteration in the GDLD patients examined, accounting for 33 of 40 (82.5%) disease alleles in our panel of families. Protein expression analysis revealed aggregation of the mutated, truncated protein in the perinuclear region, whereas the normal protein was distributed diffusely in the cytoplasm with a homogenous or fine granular pattern. Our successful identification of the gene that is defective in GDLD should facilitate genetic diagnosis and potentially treatment of the disease, and enhance general understanding of the mechanisms of amyloidosis.
AB - Gelatinous drop-like corneal dystrophy (GDLD; OMIM 204870) is an autosomal recessive disorder characterized by severe corneal amyloidosis leading to blindness, with an incidence of 1 in 300,000 in Japan. Our previous genetic linkage study localized the gene responsible to a 2.6-cM internal on chromosome 1p (ref. 6). Clinical manifestations, which appear in the first decade of life, include blurred vision, photophobia and foreign- body sensation. By the third decade, raised, yellowish-grey, gelatinous masses severely impair visual acuity, and lamellar keratoplasty is required for most patients. Here we report DNA sequencing, cDNA cloning and mutational analyses of four deleterious mutations (Q118X, 632delA, Q207X and S170X) in M1S1 (formerly TROP2 and GA733-1), encoding a gastrointestinal tumour- associated antigen. The Q118X mutation was the most common alteration in the GDLD patients examined, accounting for 33 of 40 (82.5%) disease alleles in our panel of families. Protein expression analysis revealed aggregation of the mutated, truncated protein in the perinuclear region, whereas the normal protein was distributed diffusely in the cytoplasm with a homogenous or fine granular pattern. Our successful identification of the gene that is defective in GDLD should facilitate genetic diagnosis and potentially treatment of the disease, and enhance general understanding of the mechanisms of amyloidosis.
UR - http://www.scopus.com/inward/record.url?scp=0032900158&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032900158&partnerID=8YFLogxK
U2 - 10.1038/7759
DO - 10.1038/7759
M3 - Article
C2 - 10192395
AN - SCOPUS:0032900158
SN - 1061-4036
VL - 21
SP - 420
EP - 423
JO - Nature Genetics
JF - Nature Genetics
IS - 4
ER -